This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Annexin Pharmaceuticals Beheer
Beheer criteriumcontroles 1/4
Annexin Pharmaceuticals' CEO is Anders Haegerstrand, appointed in Oct 2019, has a tenure of 4.67 years. directly owns 0.28% of the company’s shares, worth SEK445.22K. The average tenure of the management team and the board of directors is 3.2 years and 0.9 years respectively.
Belangrijke informatie
Anders Haegerstrand
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 4.7yrs |
| Eigendom CEO | 0.3% |
| Management gemiddelde ambtstermijn | 3.2yrs |
| Gemiddelde ambtstermijn bestuur | less than a year |
Recente managementupdates
Recent updates
CEO
Anders Haegerstrand (63 yo)
4.7yrs
Tenure
Dr. Anders Haegerstrand, M.D. Ph.D. is Chief Executive Officer at Annexin Pharmaceuticals AB (publ) since October 2019. He served as Director at Annexin Pharmaceuticals AB since 2018 until 2020. He served...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Executive Officer | 4.7yrs | geen gegevens | 0.28% SEK 445.2k | |
| Chief Financial Officer | 1.2yrs | geen gegevens | geen gegevens | |
| Chief Operating Officer | 6.4yrs | geen gegevens | 0.055% SEK 85.7k | |
| Chief Scientific & Medical Officer | 8.4yrs | geen gegevens | geen gegevens | |
| Head of CMC | 3.2yrs | geen gegevens | geen gegevens | |
| Therapeutic Area Head of Ophthalmology | 2.3yrs | geen gegevens | geen gegevens | |
| Head of Oncology of Therapy Area | 1.4yrs | geen gegevens | geen gegevens |
3.2yrs
Gemiddelde duur
52.5yo
Gemiddelde leeftijd
Ervaren management: ANNX BTA's management team is considered experienced (3.2 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Independent Chairman of the Board | less than a year | geen gegevens | geen gegevens | |
| Independent Director | 7.4yrs | geen gegevens | 0.18% SEK 289.3k | |
| Director | less than a year | geen gegevens | 25.89% SEK 40.6m | |
| Independent Director | 1.4yrs | geen gegevens | geen gegevens |
0.9yrs
Gemiddelde duur
73yo
Gemiddelde leeftijd
Ervaren bestuur: ANNX BTA's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.